. Overview We are a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using our patented iSPERSE technology. Our proprietary product pipeline includes treatments for central nervous system (CNS) disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) and allergic bronchopulmonary aspergillosis ...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001493152-26-008130 | EDGAR | 73K words |
| 2025-03-21 | 2024-12-31 | 0001493152-25-011084 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001493152-24-011630 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001493152-23-009609 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001493152-22-007957 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001493152-21-006602 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001193125-20-086168 | EDGAR | — |
| 2019-02-19 | 2018-12-31 | 0001193125-19-043624 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0001193125-18-080793 | EDGAR | — |
| 2017-03-10 | 2016-12-31 | 0001193125-17-077912 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-16 | 2025-09-30 | 0001493152-25-018256 | EDGAR | 16K words |
| 2025-08-06 | 2025-06-30 | 0001641172-25-022357 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010533 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001493152-24-044163 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031478 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001493152-24-018579 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040012 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027468 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016514 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031256 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001493152-22-021838 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-012940 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001493152-26-013266 | EDGAR | 57K words |
| 2026-03-02 | 0001493152-26-008449 | EDGAR | — |
| 2026-02-26 | 0001493152-26-008129 | EDGAR | — |
| 2025-12-18 | 0001493152-25-028283 | EDGAR | — |
| 2025-10-16 | 0001493152-25-018252 | EDGAR | — |
| 2025-08-06 | 0001641172-25-022354 | EDGAR | — |
| 2025-06-16 | 0001641172-25-015249 | EDGAR | — |
| 2025-05-15 | 0001641172-25-010525 | EDGAR | — |
| 2025-04-10 | 0001641172-25-003620 | EDGAR | — |
| 2025-04-08 | 0001641172-25-003216 | EDGAR | — |
292 total filings indexed. 260 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001574235 |
| Ticker | PULM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.pulmatrix.com |
| Listed | 2014-03-21 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PULM (~200 tokens, structured JSON with cryptographic provenance)